Journal of Experimental Medicine, Vol 178, 1453-1458, Copyright © 1993 by Rockefeller University Press

ARTICLES

Epitope-specific enhancement of antigen presentation by invariant chain

F Momburg, S Fuchs, J Drexler, R Busch, M Post, GJ Hammerling and L Adorini
Tumor Immunology Program, German Cancer Research Center, Heidelberg.

The MHC class II-associated invariant chain (Ii) is involved in the intracellular sorting of class II molecules to the endocytic pathway where peptides from processed exogenous antigens are bound, and thereby Ii is thought to enhance antigen presentation. Here we demonstrate that presentation of only one out of five epitopes of a given antigen is augmented by Ii. We have compared the presentation of five different epitopes derived from hen egg white lysozyme (HEL) to Ak-restricted T hybridomas by rat-2 fibroblasts transfected with A alpha k and A beta k (RKK) and RKK cells supertransfected with the mouse invariant chain (RKKI). Only the presentation of the HEL epitope 46-61 was enhanced whereas the presentation of the HEL epitopes 25-43, 34-45, 112-124, and 116-129 was unchanged or even slightly diminished in RKKI cells. The presentation of the epitopes 25-43 and 34-45 was virtually insensitive to the lysosomotropic reagent chloroquine. Brefeldin A (BFA), which inhibits protein egress from the endoplasmic reticulum, blocked the presentation of all epitopes tested in RKKI cells. In contrast, in Ii- negative RKK cells only the presentation of the epitope HEL(46-61) was inhibited by BFA and the presentation of the epitopes 25-43 and 34-45 was only slightly impaired. These findings suggest that Ii may target class II molecules to selected endosomal subcompartments involved in the processing of different peptides derived from an endocytosed antigen. As a result, the enhancement of the class II-restricted presentation in Ii expressing cells appears to be epitope specific rather than antigen specific.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Yang, H., Kala, M., Scott, B. G., Goluszko, E., Chapman, H. A., Christadoss, P. (2005). Cathepsin S Is Required for Murine Autoimmune Myasthenia Gravis Pathogenesis. J. Immunol. 174: 1729-1737 [Abstract] [Full Text]  
• Lovitch, S. B., Petzold, S. J., Unanue, E. R. (2003). Cutting Edge: H-2DM Is Responsible for the Large Differences in Presentation Among Peptides Selected by I-Ak During Antigen Processing. J. Immunol. 171: 2183-2186 [Abstract] [Full Text]  
• Koonce, C. H., Wutz, G., Robertson, E. J., Vogt, A. B., Kropshofer, H., Bikoff, E. K. (2003). DM Loss in k Haplotype Mice Reveals Isotype-Specific Chaperone Requirements. J. Immunol. 170: 3751-3761 [Abstract] [Full Text]  
• Forestier, C., Deleuil, F., Lapaque, N., Moreno, E., Gorvel, J.-P. (2000). Brucella abortus Lipopolysaccharide in Murine Peritoneal Macrophages Acts as a Down-Regulator of T Cell Activation. J. Immunol. 165: 5202-5210 [Abstract] [Full Text]  
• Guermonprez, P., Lo-Man, R., Sedlik, C., Rojas, M.-J., Poljak, R. J., Leclerc, C. (1999). mAb against hen egg-white lysozyme regulate its presentation to CD4+ T cells. Int Immunol 11: 1863-1872 [Abstract] [Full Text]  
• Forquet, F., Barois, N., Machy, P., Trucy, J., Zimmermann, V. S., Leserman, L., Davoust, J. (1999). Presentation of Antigens Internalized Through the B Cell Receptor Requires Newly Synthesized MHC Class II Molecules. J. Immunol. 162: 3408-3416 [Abstract] [Full Text]  
• Zimmermann, V. S., Rovere, P., Trucy, J., Serre, K., Machy, P., Forquet, F., Leserman, L., Davoust, J. (1999). Engagement of B Cell Receptor Regulates the Invariant Chain-Dependent MHC Class II Presentation Pathway. J. Immunol. 162: 2495-2502 [Abstract] [Full Text]  
• Thayer, W. P., Ignatowicz, L., Weber, D. A., Jensen, P. E. (1999). Class II-Associated Invariant Chain Peptide-Independent Binding of Invariant Chain to Class II MHC molecules. J. Immunol. 162: 1502-1509 [Abstract] [Full Text]  
• Peterson, M., Sant, A. J. (1998). The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM. J. Immunol. 161: 2961-2967 [Abstract] [Full Text]  
• Arunachalam, B., Pan, M., Cresswell, P. (1998). Intracellular Formation and Cell Surface Expression of a Complex of an Intact Lysosomal Protein and MHC Class II Molecules. J. Immunol. 160: 5797-5806 [Abstract] [Full Text]  
• Lo-Man, R., Langeveld, J. P. M., Martineau, P., Hofnung, M., Meloen, R. H., Leclerc, C. (1998). Immunodominance Does Not Result from Peptide Competition for MHC Class II Presentation. J. Immunol. 160: 1759-1766 [Abstract] [Full Text]  
• Rovere, P., Zimmermann, V. S., Forquet, F., Demandolx, D., Trucy, J., Ricciardi-Castagnoli, P., Davoust, J. (1998). Dendritic cell maturation and antigen presentation in the absence of invariant chain. Proc. Natl. Acad. Sci. USA 95: 1067-1072 [Abstract] [Full Text]  
• Zhong, G., e Sousa, C. R., Germain, R. N. (1997). Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc. Natl. Acad. Sci. USA 94: 13856-13861 [Abstract] [Full Text]  
• Tourne, S., Miyazaki, T., Wolf, P., Ploegh, H., Benoist, C., Mathis, D. (1997). Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. Proc. Natl. Acad. Sci. USA 94: 9255-9260 [Abstract] [Full Text]  
• Zhong, G., Romagnoli, P., Germain, R. N. (1997). Related Leucine-based Cytoplasmic Targeting Signals in Invariant Chain and Major Histocompatibility Complex Class II Molecules Control Endocytic Presentation of Distinct Determinants in a Single Protein. JEM 185: 429-438 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS